ArisGlobal Announces the All-New LifeSphere® Regulatory Platform, Bringing Game-Changing Efficiency to Regulatory Information Management

MIAMI, FL, UNITED STATES - Jun 8, 2020 - ArisGlobal, the leading provider of software that automates core drug development functions for over 300 global life sciences companies, today announced the launch of of LifeSphere® Regulatory, an all-new cloud platform that addresses the full end-to-end regulatory management process in a simple, unified suite

Kyruus Secures $30 Million Investment from Francisco Partners

BOSTON, MA, UNITED STATES - Jun 10, 2020 -  Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that it has obtained $30 million in new funding from Francisco Partners, a leading global technology-focused private equity firm with extensive experience in healthcare IT

Dotmatics receives ISO 9001:2015 certification for scientific informatics technology

BISHOP’S STORTFORD, UK - Jun 3, 2020 - Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced it has achieved certification to the internationally recognised standard ISO 9001:2015 for its quality management system (QMS)

Gendius kicks off funding round to further grow its market-leading smart diabetes management platform

MANCHESTER, UNITED KINGDOM - Jun 9, 2020 -

• Intellin® is now the world's fastest-growing diabetes management app.
• It has seen rapid growth since the outbreak of Covid-19, with more than 10,000 downloads a week so far in May 2020x

ICENI DIAGNOSTICS CORONAVIRUS TESTS WINS FUNDING FROM INNOVATE UK

CAMBRIDGE, UNITED KINGDOM - Jun 9, 2020 - Iceni Diagnostics, developers of a rapid test for coronavirus, is one of the 800 companies to benefit from a £20 million government fund

DNAnexus Completes $100 Million Financing

MOUNTAIN VIEW, CA, UNITED STATES - Jun 9, 2020 - DNAnexus, Inc., the leading cloud-based SaaS company serving the global life science community, today announced the closing of a $100 million financing round

Olaris CEO Elected to Personalized Medicine Coalition Board of Directors

WALTHAM, MA, UNITED STATES - Jun 9, 2020 - Olaris, a precision medicine company that is working to fundamentally change how diseases are treated, today announced that The Personalized Medicine Coalition (PMC) has elected Olaris CEO and Founder Dr

Florence Healthcare Names Melinda Rodriguez Winner of The Florence Effect Initiative

ATLANTA, GA, UNITED STATES - Jun 8, 2020 -  Florence Healthcare, the leading platform for remote-enabled electronic document workflow management in clinical trials, is proud to name Melinda Rodriguez, Director of Regulatory Services at Elligo Health Research, as the winner of The Florence Effect initiative

The RSA Group reveals new global brand

LONDON, UK - Jun 5, 2020 - The RSA Group, the leading global specialist in Life Sciences Executive Search, is excited to share its new global brand and website

BOC Sciences Offers Raw Chemical Materials for Manufacturing Test Kits and Vaccines

SHIRLEY, NY - Jun 5, 2020 - Recently, BOC Sciences, a New York-based chemical and pharmaceutical raw material supplier, announced to offer raw chemical materials needed for the manufacture of test kits and vaccines to meet the challenges facing the global pharmaceutical industry during the coronavirus outbreak

Lyniate Facilitates Interoperability Ecosystem via Strategic Partnerships

BOSTON, MA, UNITED STATES - Jun 3, 2020 - Boston, MA - June 3, 2020 - Lyniate, a global leader in healthcare data interoperability, today announced that as part of its effort to create a truly interoperable ecosystem in healthcare, it has partnered with two healthcare technology vendors: BioIntelliSense and HICG

Greenphire Launches New Clinical Trial Budget Build and Negotiation Solution, EnvisiX

KING OF PRUSSIA, PA, UNITED STATES - Jun 2, 2020 - Greenphire, the global leader in financial lifecycle management for clinical trials, today announced the launch of EnvisiX to address the budgeting challenges experienced by global sponsors and CROs during study start-up

InSysBio to announce the launch of QSP model of COVID-19

MOSCOW, RUSSIA - Jun 2, 2020 - InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces the launch of its fundamentally new project in response to the ongoing global threat, the open source QSP model of COVID-19

UCB and N-SIDE increase their strategic collaboration

LOUVAIN-LA-NEUVE, BELGIUM - Jun 2, 2020 - N-SIDE, provider of innovative software and strategic consulting services, announced that UCB has signed a 3-year agreement increasing their collaboration in clinical supply optimization

Domainex announces the appointment of Dr. Eddy Littler as non-executive Chairman

CAMBRIDGE, UK - Jun 2, 2020 - Following the retirement of Tony Brampton, Eddy Littler has been appointed as non-executive Chairman of Domainex Ltd

MeMed Receives CE Mark for Two Pioneering Technologies: The MeMed BV™ Test and MeMed Key™ Point-of-Need Platform

HAIFA, ISRAEL - Jun 2, 2020 -   MeMed Ltd., a leader in host response-based solutions, today announced that it has received a CE Mark in Europe for use of its diagnostic test MeMed BV™ and point-of-need platform MeMed Key™

Almac Clinical Technologies Introduces Simplify™, an Advanced IRT Solution Enabling Faster Clinical Trials Start-up

SOUDERTON, PA, UNITED STATES - Jun 1, 2020 - Almac Clinical Technologies, part of the Almac Group, today announced the availability of SimplifyTM, a next-generation Interactive Response Technology (IRT) solution that comes standard with an array of configurable functionality designed to accelerate the study start-up process with greater efficiency

Imvax Appoints Iphigenia Leonidou Koumenis as Head of Clinical Operations

PHILADELPHIA, PA, UNITED STATES - Jun 1, 2020 - PHILADELPHIA, PA (June 1, 2020)  – Imvax, Inc., a clinical-stage biotechnology company, today announced that Iphigenia (“Effie”) Leonidou Koumenis has been appointed as Head of Clinical Operations

Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial Officer

NOTTINGHAM, UNITED KINGDOM - Jun 1, 2020 -   Albumedix Ltd. (‘Albumedix’), the world leader in recombinant human albumin (rAlb), announced today the strengthening of its Executive Leadership with the appointment of Gregor Kawaletz as Chief Commercial Officer, as of June 1st, 2020

Accumen Launches Hospital Lab Crisis Preparedness Program

PHOENIX, AZ - May 29, 2020 - Accumen Inc. is helping healthcare get better, faster. As an extension of its ongoing effort to provide resources that enable hospitals to manage every phase of the COVID-19 pandemic optimally, today Accumen launched its Lab Crisis Preparedness Program to help hospitals ensure their laboratories are able to meet the testing needs of their health system and surrounding communities